AI English summary of an SEC filing — figures as filed
Universal Health Services UHSThe company said UHS net income attributable to UHS was $316.7 million ($4.80 per diluted share) for Q1 2025, compared with $261.8 million ($3.82 per share) for Q1 2024. Net revenues rose 6.7% to $4.100 billion.
Key points
AI summaryThe company said UHS net income attributable to UHS was $316.7 million ($4.80 per diluted share) for Q1 2025, compared with $261.8 million ($3.82 per share) for Q1 2024. Net revenues rose 6.7% to $4.100 billion.
Universal Health Services said adjusted net income attributable to UHS for Q1 2025 was $319.5 million ($4.84 per diluted share), and Adjusted EBITDA net of NCI was $598.2 million. The company said the Q1 2024 figures were $253.1 million ($3.70) and $525.8 million, respectively.
UHS said net cash provided by operating activities was $360 million for Q1 2025, a decrease of $36 million from $396 million for Q1 2024. The company cited an unfavorable change of $144 million in accounts receivable, which included approximately $82 million related to the Nevada state directed payment program.
As of March 31, 2025, the company said it had $1.02 billion of aggregate available borrowing capacity under its $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit. During Q1 2025, the company repurchased approximately 1.0 million shares at an aggregate cost of approximately $180.6 million, and it had approximately $643.7 million remaining under its stock repurchase authorization.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q1 2025 Net Income and Net Revenues
The company said UHS net income attributable to UHS was $316.7 million ($4.80 per diluted share) for Q1 2025, compared with $261.8 million ($3.82 per share) for Q1 2024. Net revenues rose 6.7% to $4.100 billion.
Source · Based on the filing body and exhibits
Adjusted Net Income and Adjusted EBITDA
Universal Health Services said adjusted net income attributable to UHS for Q1 2025 was $319.5 million ($4.84 per diluted share), and Adjusted EBITDA net of NCI was $598.2 million. The company said the Q1 2024 figures were $253.1 million ($3.70) and $525.8 million, respectively.
Source · Based on the filing body and exhibits
Q1 2025 Operating Cash Flow and Accounts Receivable
UHS said net cash provided by operating activities was $360 million for Q1 2025, a decrease of $36 million from $396 million for Q1 2024. The company cited an unfavorable change of $144 million in accounts receivable, which included approximately $82 million related to the Nevada state directed payment program.
Source · Based on the filing body and exhibits
Liquidity and Share Repurchases
As of March 31, 2025, the company said it had $1.02 billion of aggregate available borrowing capacity under its $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit. During Q1 2025, the company repurchased approximately 1.0 million shares at an aggregate cost of approximately $180.6 million, and it had approximately $643.7 million remaining under its stock repurchase authorization.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…